Advertisement

Biological Trace Element Research

, Volume 186, Issue 1, pp 85–90 | Cite as

Association of TSHR Gene Copy Number Variation with TSH Abnormalities

  • Yi Pang
  • Yunfeng Guan
  • Xing Jin
  • Hongmei Shen
  • Lixiang Liu
  • Qingzhen Jia
  • Fangang Meng
  • Xiaoye Zhang
Article
  • 90 Downloads

Abstract

Thyroid-stimulating hormone (TSH) is secreted by the pituitary gland and promotes thyroid growth and function, with increased TSH levels typically associated with hypothyroidism. By consulting the literature, we found that the TSHR, PAX8, and PDE4B genes are associated with thyroid function. Recently, copy number variations (CNVs) have been used as genetic markers to investigate inter-individual variation. Therefore, we investigated the relationship between the TSHR, PAX8, and PDE4B gene CNVs and TSH abnormalities, by calculating variations in gene copy number. Four hundred and eighty-one participants, 232 healthy controls and 249 patients with TSH abnormalities, were selected from three distinct areas in China with different iodine statuses. RT-PCR was used to detect CNVs. Urinary iodine concentrations (UIC) were measured by As3+–Ce4+ catalytic spectrophotometry. There was an association between a CNV at the TSHR gene and TSH abnormalities (p = 0.002). The distribution of PAX8 and PDE4B gene CNVs between patients with TSH abnormalities and healthy controls was not significantly different. UIC > 200 μg/l (OR = 1.49, 95% CI = 1.01–2.22) and the TSHR gene (OR = 6.01, 95% CI = 1.96–18.41) were found to be risk factors for TSH abnormalities. PAX8 and PDE4B gene CNVs were not significantly associated with TSH abnormalities. There was no significant interaction between UIC and any of the examined CNVs. In conclusion, the TSHR gene CNV was associated with the development of TSH abnormalities. No significant associations were revealed between urinary iodine levels and candidate gene CNVs.

Keywords

TSH abnormalities Copy number variation TSHR PAX8 PDE4B 

Notes

Acknowledgements

We are grateful for the assistance by the Institute for Prevention and Treatment of Endemic Disease of Shanxi Province. And we also thank the colleagues who took part in the survey for their dedication and support.

Authors’ Contribution

The contribution of each author is as follows: Hongmei Shen and Yi Pang designed the research; Yi Pang, Yunfeng Guan, Xing Jin, Hongmei Shen, Lixiang Liu, Qingzhen Jia, Fangang Meng, and Xiaoye Zhang conducted the research; Yi Pang analyzed the data and wrote the paper; Hongmei Shen had primary responsibility for the final content. All authors read and approved the final manuscript.

Funding

This study was funded by the National Natural Science Foundation of China (Grant No. 81573098).

Compliance with Ethical Standards

All the procedures used in this experiment were reviewed and approved by the biomedical research ethics committee of Harbin Medical University.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Brand OJ, Barrett JC, Simmonds MJ, Newby PR, Mccabe CJ, Bruce CK, Kysela B, Carrsmith JD, Brix T, Hunt PJ (2009) Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves’ disease. Hum Mol Genet 18(9):1704–1713CrossRefGoogle Scholar
  2. 2.
    Brand OJ, Gough SC (2010) Genetics of thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol 322(1–2):135–143CrossRefGoogle Scholar
  3. 3.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF (2008) Influence of the TSH receptor gene on susceptibility to Graves’ disease and Graves’ ophthalmopathy. Thyroid Off J Am Thyroid Assoc 18(11):1201–1206CrossRefGoogle Scholar
  4. 4.
    Liao WL, Wan L, Wang TY, Chen CC, Tse SS, Lu CH, Tsai FJ (2014) Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan. BMC Ophthalmol 14(1):15CrossRefGoogle Scholar
  5. 5.
    Liu S, Wang X, Zou H, Ge Y, Wang F, Wang Y, Yan S, Xia H, Xing M (2017) Identification and characterization of novel PAX8 mutations in Congenital Hypothyroidism(CH) in a Chinese population. Oncotarget 8(5):8707–8716PubMedPubMedCentralGoogle Scholar
  6. 6.
    Wang F, Liu C, Jia X, Liu X, Xu Y, Yan S, Jia X, Huang Z, Liu S, Gu M (2017) Next-generation sequencing of NKX2.1, FOXE1, PAX8, NKX2.5, and TSHR in 100 Chinese patients with congenital hypothyroidism and athyreosis. Clin Chim Acta 470:36–41CrossRefGoogle Scholar
  7. 7.
    Van dHL, Padmos RC, Drexhage RC, De WH, Berghout A, Drexhage HA (2010) An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients. J Clin Endocrinol Metab 95(4):1962CrossRefGoogle Scholar
  8. 8.
    Takahashi SI, Nedachi T, Fukushima T, Umesaki K, Ito Y, Hakuno F, Van Wyk JJ, Conti M (2001) Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells. Biochimica Et Biophysica Acta Molecular Cell Research 1540(1):68–81CrossRefGoogle Scholar
  9. 9.
    Pezer Ž, Harr B, Teschke M, Babiker H, Tautz D (2015) Divergence patterns of genic copy number variation in natural populations of the house mouse (Mus musculus domesticus) reveal three conserved genes with major population-specific expansions. Genome Res 25(8):1114–1124CrossRefGoogle Scholar
  10. 10.
    Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459(7246):569–573CrossRefGoogle Scholar
  11. 11.
    Sebat J, Lakshmi B, Malhotra D, Troge J, Lesemartin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J (2007) Strong association of de novo copy number mutations with autism. Science 316(5823):445–449CrossRefGoogle Scholar
  12. 12.
    Walsh T, Mcclellan JM, Mccarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539–543CrossRefGoogle Scholar
  13. 13.
    Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE (2009) Copy number variation at 1q21.1 associated with neuroblastoma. Nature 459(7249):987–991CrossRefGoogle Scholar
  14. 14.
    Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Sun J, Wiklund F, Wiley K, Isaacs SD (2009) Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res 69(6):2176–2179CrossRefGoogle Scholar
  15. 15.
    Shlien A, Malkin D (2010) Copy number variations and cancer susceptibility. Curr Opin Oncol 22(1):55–63CrossRefGoogle Scholar
  16. 16.
    Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, De SA, Blakemore AI (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39(6):721–723CrossRefGoogle Scholar
  17. 17.
    Kelley J, Johnson MR, Alarcón GS, Kimberly RP, Edberg JC (2007) Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum 56(10):3375–3378CrossRefGoogle Scholar
  18. 18.
    Mamtani M, Anaya JM, He W, Ahuja SK (2010) Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 11(2):155–160CrossRefGoogle Scholar
  19. 19.
    Ptacek T, Li X, Kelley JM, Edberg JC (2008) Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res 123(1–4):142–147CrossRefGoogle Scholar
  20. 20.
    Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, Mcgovern NN, Condliffe AM, Chilvers ER (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205(7):1573–1582CrossRefGoogle Scholar
  21. 21.
    Lin CH, Lin YC, Wu JY, Pan WH, Chen YT, Fann CSJ (2009) A genome-wide survey of copy number variations in Han Chinese residing in Taiwan. Genomics 94(4):241–246CrossRefGoogle Scholar
  22. 22.
    Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W (2006) Global variation in copy number in the human genome. Nature 444(7118):444CrossRefGoogle Scholar
  23. 23.
    Yan YQ, Zhang YP, Liu LJ, Liu JY, Wei-Dong LI, Hua JL, Chen ZP, University TM, Tianjin (2004) Method for measuring iodine in urine by As3+-Ce4+ catalytic spectrophotometry using ammonium persulfate digestion. Chin J EndemiolGoogle Scholar
  24. 24.
    Zhang L, Zhou Y, Cheng C, Cui H, Cheng L (2015) Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet 96(4):597–611CrossRefGoogle Scholar
  25. 25.
    Jeong YH, Kim D, Lee JW, Rhee Y, Nam KH, Yun M, Kim CK (2015) Pituitary 18F-FDG uptake correlates with serum TSH levels in subjects with diffuse thyroid 18F-FDG uptake. Clin Nucl Med 40(8):632–636CrossRefGoogle Scholar
  26. 26.
    Albader A, Zawawi F, Singer Z, Mlynarek A, Hier M, Tamilia M, Payne R (2015) Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer? Otolaryngologia polska: The Polish otolaryngology 69(3):21Google Scholar
  27. 27.
    Hollox EJ, Hoh BP (2014) Human gene copy number variation and infectious disease. Hum Genet 133(10):1217–1233CrossRefGoogle Scholar
  28. 28.
    Stefansson H, Meyerlindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, Bjornsdottir G, Walters GB, Jonsdottir GA, Doyle OM (2014) CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505(7483):361–366CrossRefGoogle Scholar
  29. 29.
    Dajani R, Li J, Wei Z, Glessner JT, Xiao C, Cardinale CJ, Pellegrino R, Wang T, Hakooz N, Khader Y (2015) CNV analysis associates AKNAD1 with Type-2 diabetes in Jordan subpopulations. Sci Rep 5:13391CrossRefGoogle Scholar
  30. 30.
    Duschek S, Wörsching J, Ga RDP (2013) Interactions between autonomic cardiovascular regulation and cortical activity: a CNV study. Psychophysiology 50(4):388–397CrossRefGoogle Scholar
  31. 31.
    Aerts E, Beckers S, Zegers D, Van HK, Massa G, Verrijken A, Verhulst SL, Van Gaal LF, Van HW (2016) CNV analysis and mutation screening indicate an important role for the NPY4R gene in human obesity. Obesity 24(4):970–976CrossRefGoogle Scholar
  32. 32.
    Mansourian AR (2011) Central dogma in thyroid dysfunction: a review on structure modification of TSHR as a cornerstone for thyroid abnormalities. Pakistan Journal of Biological Sciences Pjbs 14(3):170–181CrossRefGoogle Scholar
  33. 33.
    Kopp P (2001) Human genome and diseases: review—the TSH receptor and its role in thyroid disease. Cell Mol Life Sci Cmls 58(9):1301–1322CrossRefGoogle Scholar
  34. 34.
    Rossi DL, Acebrón A, Santisteban P (1995) Function of the homeo and paired domain proteins TTF-1 and Pax-8 in thyroid cell proliferation. J Biol Chem 270(39):23139–23142CrossRefGoogle Scholar
  35. 35.
    Arnaud-Lopez L, Usala G, Ceresini G, Mitchell B, Pilia M, Piras M, Sestu N, Maschio A, Busonero F, Albai G (2008) Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 82(6):1270–1280CrossRefGoogle Scholar
  36. 36.
    Agretti P, Marco GD, Cosmo CD, Bagattini B, Ferrarini E, Montanelli L, Vitti P, Tonacchera M (2014) Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism. J Endocrinol Investig 37(2):189–194CrossRefGoogle Scholar
  37. 37.
    Li N, Jiang Y, Shan Z, Teng W (2012) Prolonged high iodine intake is associated with inhibition of type 2 deiodinase activity in pituitary and elevation of serum thyrotropin levels. Br J Nutr 107(5):674–682CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Key Laboratory of Etiology and Epidemiology, National Health and Family Planning Commission, Center for Endemic Disease Control, Chinese Center for Disease Control and PreventionHarbin Medical UniversityHarbinChina
  2. 2.Institute for Endemic Disease Prevention and Treatment of Shanxi ProvinceLinfenChina

Personalised recommendations